Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
Public ClinicalTrials.gov record NCT04284657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an one-year open-label study to determine treatment efficacy and feasibility of a trial that uses open-label interventions in ADPKD patients.
Study identification
- NCT ID
- NCT04284657
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1 participant
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 29, 2019
- Primary completion
- Aug 3, 2025
- Completion
- Aug 3, 2025
- Last update posted
- Aug 5, 2025
2019 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Keck School of Medicine of University of Southern California | Los Angeles | California | 90033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Autosomal Dominant Polycystic Kidney Disease trials
Other public records listing Autosomal Dominant Polycystic Kidney Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT07745920: Managing Depressive Symptoms in ADPKD Recruiting
- NCT06902558: ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) Recruiting
- NCT07228364: Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease Recruiting
- NCT05193981: A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD Active, not recruiting
- NCT05288998: Intrarenal Microvasculature in ADPKD Active, not recruiting
- NCT04344769: Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04284657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2025 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04284657 live on ClinicalTrials.gov.